
ImpediMed Ltd
ASX:IPD

Intrinsic Value
The intrinsic value of one
IPD
stock under the Base Case scenario is
0.067
AUD.
Compared to the current market price of 0.042 AUD,
ImpediMed Ltd
is
Undervalued by 38%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
ImpediMed Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
ImpediMed Ltd
Balance Sheet Decomposition
ImpediMed Ltd
Current Assets | 23.2m |
Cash & Short-Term Investments | 17.7m |
Receivables | 3.6m |
Other Current Assets | 1.9m |
Non-Current Assets | 16m |
Long-Term Investments | 51k |
PP&E | 1.2m |
Intangibles | 14.7m |
Free Cash Flow Analysis
ImpediMed Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
ImpediMed Ltd
Revenue
|
11.5m
AUD
|
Cost of Revenue
|
-1.4m
AUD
|
Gross Profit
|
10.1m
AUD
|
Operating Expenses
|
-32.4m
AUD
|
Operating Income
|
-22.3m
AUD
|
Other Expenses
|
1.1m
AUD
|
Net Income
|
-21.2m
AUD
|
IPD Profitability Score
Profitability Due Diligence
ImpediMed Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Score
ImpediMed Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
IPD Solvency Score
Solvency Due Diligence
ImpediMed Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Score
ImpediMed Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IPD Price Targets Summary
ImpediMed Ltd
According to Wall Street analysts, the average 1-year price target for
IPD
is 0.138 AUD
with a low forecast of 0.091 AUD and a high forecast of 0.179 AUD.
Dividends
Current shareholder yield for IPD is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
IPD
stock under the Base Case scenario is
0.067
AUD.
Compared to the current market price of 0.042 AUD,
ImpediMed Ltd
is
Undervalued by 38%.